In addition, since the optimal PSA expression threshold for clinical samples has not been determined [4], routine PSA screening sometimes leads to over-diagnosis and over-treatment of indolent PCa [5, 6]. The gene discussed is KLK3; the disease is posterior cortical atrophy.